A conversation with Dr. Jasmohan Bajaj, MD, PhD, Associate Professor – Department of Internal Medicine, Virginia Commonwealth University
Active in research, Dr Bajaj has served as a principal or co-investigator for numerous clinical trials in hepatic encephalopathy, chronic liver disease and microbiome. He is an Associate Editor for the American Journal of Gastroenterology and Journal of Clinical and Experimental Hepatology and is on the editorial board for Journal of Hepatology and Liver Transplantation.
Dr Bajaj is the Chairperson for the North American Consortium for Study of End-stage Liver Disease and is the President of the International Society for Hepatic Encephalopathy and Nitrogen Metabolism.
BRW: What do you hope the audience will learn from this webinar?
I hope that participants can understand how different roles within the hepatic encephalopathy (HE) management pathway can work synergistically to optimise outcomes. They will also learn of recently published data in the field of and the implications of these data for clinical practice.
BRW: What discussions do you look forward to having with the audience?
Personally I am looking forward to sharing results from a North American multicentre study that I have been involved in, which evaluates the role of junior doctors in HE management.
BRW: What do you enjoy most about your role?
I like patient-reported perspectives in HE and how this can inform our future strategies.
BRW: How did you get into your speciality?
I finished my training in several parts of the world and have benefited from the varying perspectives everywhere. What is consistent are the difficulties in determining how the brain is affected in patients with liver disease and developing strategies to define this remains my goal.
BRW: Where is your favourite place in the world and why?
Istanbul, comingling of old and new and Asia and Europe
Join Dr Jasmohan Bajaj, MD, PhD, on 25th January for a webinar entitled ‘Sharing Perspectives: What is new in the field of liver decompensation with hepatic encephalopathy (HE)?’ at 12:00 GMT/13:00 CET.